Optimizing Communication Between Oncologists and Pathologists on Cancer Biomarker TestingVideo Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library
Drs Geoffrey Oxnard and Lauren Ritterhouse discuss the best ways oncologists and pathologists can communicate about molecular biomarker testing for individual patients as well as on strategies for incorporating new biomarkers into testing panels.
As more oral oncolytics are developed, choosing the right regimen for prolonged disease-free survival presents a major patient management challenge. Dixie-Lee Esseltine, MD and George Mulligan, PhD explain that healthcare practitioners will have to make informed choices by balancing information emerging across similar trials.
Grant Lawless discusses the long term goal of personalized medicine as it relates to the Affordable Care Act